Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Citizens & Northern Director Buys 178 Shares in September

A Form 4 filed on September 8, 2026, reports that Frank G. Pellegrino, a director of Citizens & Northern Corp (NASDAQ:CZNC), purchased 178 shares of common stock on September 4, 2026, under a pre-established written trading plan.

Nitish Kishor | 08 September 2026

Horace Mann Director Perry Hines Sells 3,237 Shares

A Form 4 filed on September 8, 2026 with the U.S. Securities and Exchange Commission disclosed that Perry G. Hines, a director at Horace Mann Educators Corp /DE/ (NYSE:HMN), sold 3,237 shares of common stock on September 3, 2026.

Nitish Kishor | 08 September 2026

Horace Mann General Counsel Sells 2,054 Shares

Donald M. Carley, General Counsel of Horace Mann Educators Corp /DE/, filed a Form 4 on September 8, 2026, disclosing the sale of 2,054 shares of common stock on September 3, 2026.

Anjali Anand | 08 September 2026

Alamo Group Director Transfers 2,844 Shares to Family Trust

Director Nina C. Grooms filed a Form 4 with the SEC on September 8, 2026, reporting a gift transaction in Alamo Group Inc. common stock dated September 3, 2026.

Anjali Anand | 08 September 2026

Riskified Director Sells 50,000 Shares in September 2026

A Form 4 filed on September 8, 2026, discloses that Erez Shachar, a director of Riskified Ltd. (NYSE:RSKD), sold 50,000 Class A Ordinary Shares on September 3, 2026, at a weighted average price of $6.7202 per share.

Anjali Anand | 08 September 2026

Riskified CEO Sells 150,000 Shares Under 10b5-1 Plan

Eido Gal, Chief Executive Officer and Director of Riskified Ltd. (NASDAQ:RSKD), filed a Form 4 on September 8, 2026, disclosing the sale of 150,000 Class A Ordinary Shares on September 4, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.

Aakashdeep | 08 September 2026

Dyne Therapeutics CEO Sells Shares for Tax Withholding

A Form 4 filed on September 8, 2026, discloses that John Cox, CEO and President of Dyne Therapeutics, Inc. (NASDAQ:DYN), disposed of 5,658 shares of common stock on September 8, 2026, to satisfy tax withholding obligations tied to the vesting of restricted stock units.

Anjali Anand | 08 September 2026

Dyne Therapeutics CMO Sells Shares for Tax Withholding

Douglas Kerr, Chief Medical Officer of Dyne Therapeutics, Inc., filed a Form 4 on September 8, 2026, reporting two automatic sales of common stock on September 4 and September 8, 2026, to satisfy tax withholding obligations tied to vesting restricted stock units.

Anjali Anand | 08 September 2026

Dyne Therapeutics CCO Reports Two RSU Tax-Sale Transactions

Johanna Friedl-Naderer, Chief Commercial Officer of Dyne Therapeutics, Inc. (NASDAQ:DYN), filed a Form 4 on September 8, 2026, disclosing two automatic sales of common stock on September 4 and September 8, 2026, both executed to satisfy tax withholding obligations upon the vesting of restricted …

Shwetambri Chauhan | 08 September 2026

Seneca Foods Senior VP Sells Class A Shares

A Form 4 filed on September 8, 2026, discloses that Dean Everett Erstad, Senior VP of Sales and Marketing at Seneca Foods Corp (NASDAQ:SENEA), sold 1,587 shares of Seneca Foods Class A Common Stock on September 4, 2026.

Vinay Lochav | 08 September 2026
Support

Hi! How can we help you today?

Loading…